Newsfeeds Archive - Page 41 of 41

1 minute read

Boeing, Meta Platforms And 5 Stocks To Watch Heading Into Wednesday

July 27, 4:02 AM

With US stock futures trading higher this morning on Wednesday ahead of earnings reports from several big companies, some of the stocks that may grab investor focus today are as follows:

2 minute read

Apple, Meta, Pfizer Among Key Companies Reporting In The Week Ahead, As Earnings Pick Up Pace

By Shanthi Rexaline

July 24, 4:37 PM

Big tech earnings will flow in thick and fast in the upcoming week, providing more clarity on how supply chain disruptions and the macroeconomic malaise have impacted these companies.

AAPL

2 minute read

Recap Of Friday’s Biotech Catalysts – End Of The Day Summary

By Ragothaman Srinivasan

July 22, 5:59 PM

Bristol Myers Squibb (NYSE:BMY) received European Medicines Agency (EMA) Positive CHMP Opinion recommending approval for Opdualag (nivolumab and…

BMY

3 minute read

Psychedelics Management Updates: Two Top Companies Appoint New CEOs, Here’s What We Know

By Lara Goldstein

July 19, 2:27 PM

Two companies in the psychedelics space have chosen new chief executive officers: COMPASS Pathways (NASDAQ: CMPS) has chosen Kabir Nath, and Small Pharma will be now led by George Tziras.

BMY

2 minute read

Bristol-Myers Squibb Whale Trades For July 12

By Benzinga Insights

July 12, 5:21 PM

Someone with a lot of money to spend has taken a bearish stance on Bristol-Myers Squibb (NYSE:BMY). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

BMY

1 minute read

Hot Stocks: Tickers Moved By Traders on ‘Fast Money: Halftime Report’

By AJ Fabino

July 1, 3:44 PM

CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.

BMY

4 minute read

Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates

By Shanthi Rexaline

July 1, 5:26 AM

The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.

ACER